As shown in Fig. S3, in this study, we blocked the function of SLC2A1 using BAY-876 and discovered that it could suppress the expression of gluconeogenesis and glycogenolysis-related genes in hepatocellular carcinoma cells. This evidence concerns the gene SLC2A1 and hepatocellular carcinoma.